3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Triple Negative Breast Neoplasms
1
Precursor Cell Lymphoblastic Leukemia-Lymphoma
1
Pancreatic Neoplasms
1
Ovarian Neoplasms
1
Osteosarcoma
1
Neoplasms
1
Myelodysplastic Syndromes
1
Mesothelioma, Malignant
1
Mesothelioma
1
Lymphoma, Non-Hodgkin
1
Leukemia, Prolymphocytic, B-Cell
1
Leukemia, Myelomonocytic, Chronic
1
Leukemia, Myeloid, Acute
1
Leukemia, Lymphocytic, Chronic, B-Cell
1
Leukemia, Biphenotypic, Acute
1
Kidney Neoplasms
1
Glioma
1
Colorectal Neoplasms
1
Carcinoma, Renal Cell
1
Carcinoma, Non-Small-Cell Lung
1
Burkitt Lymphoma
1
Interventions
Temozolomide
9
Specimen Handling
6
Radiotherapy
6
Magnetic Resonance Spectroscopy
6
Radiation
5
trametinib
2
dabrafenib
2
Radiotherapy, Intensity-Modulated
2
Bevacizumab
2
vorasidenib
1
vocimagene amiretrorepvec
1
veliparib
1
trastuzumab deruxtecan
1
ribociclib
1
Vorinostat
1
Spinal Puncture
1
Protons
1
Proton Therapy
1
Pluvicto
1
Nivolumab
1
Magnetic Resonance Imaging
1
Leukapheresis
1
Irinotecan
1
Ipilimumab
1
Flucytosine
1
Everolimus
1
DNA
1
Carmustine
1
Carboplatin
1
CTLA-4 Antigen
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Astrocytoma
×
Blood Component Removal
×
30 days
×
Clear all
No trials found.